Ianchulev Tsontcho 4

Accession 0001638599-20-000346

CIK 0001682639other

View on SEC.gov Company Profile

Filed

Mar 25, 8:00 PM ET

Accepted

Mar 26, 6:17 PM ET

Size

18.3 KB

Accession

0001638599-20-000346

Insider Transaction Report

Form 4

Period: 2020-03-24

EYENOVIA, INC.EYEN

Ianchulev Tsontcho

Director

Transactions

Purchase
Common Stock, par value $.0001
2020-03-24$2.27/sh+82,431$187,118→ 508,679 total
Purchase
Class B Warrant
2020-03-24+61,823→ 61,823 total
Exercise: $2.72From: 2020-03-24Exp: 2025-03-24→ Common Stock (61,823 underlying)
Purchase
Class A Warrant
2020-03-24+41,216→ 41,216 total
Exercise: $2.27From: 2020-03-24Exp: 2021-03-24→ Common Stock (41,216 underlying)

Holdings

Common Stock, par value $.0001
(indirect: By Trust)
6,000
Stock Option (right to buy)
(indirect: By Private Medical Equity, Inc.)
Exercise: $1.24From: 2015-03-23Exp: 2025-03-23→ Common Stock (140,000 underlying)
140,000
Common Stock, par value $.0001
(indirect: By Private Medical Equity, Inc.)
606,667
Stock Option (right to buy)
Exercise: $3.11Exp: 2029-08-16→ Common Stock (183,703 underlying)
183,703
Stock Option (right to buy)
Exercise: $6.20Exp: 2028-07-24→ Common Stock (124,210 underlying)
124,210
Common Stock, par value $.0001
(indirect: By LLC)
453,333
Stock Option (right to buy)
Exercise: $1.95Exp: 2027-07-07→ Common Stock (267,370 underlying)
267,370

Footnotes (7)

[F1]On March 24, 2020, the Reporting Person purchased Units from the Issuer in a private placement, with each Unit consisting of (a) one share of the Issuer's common stock, (b) a Class A Warrant representing the right to acquire 0.5 shares of the Issuer's common stock and (c) a Class B Warrant representing the right to acquire 0.75 shares of the Issuer's common stock. The purchase price for each Unit was $2.42625 of which $2.27 was for the share of the Issuer's common stock, $0.06250 was for the Class A Warrant and $0.09375 was for the Class B Warrant.
[F2]The reporting person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose.
[F3]The exercise price per share of the Issuer's common stock issuable upon exercise of the Class A and Class B Warrants is subject to adjustment for stock splits, stock dividends and similar corporate events.
[F4]The number of shares of Issuer common stock issuable upon exercise of the Class A and Class B Warrants is subject to adjustment for stock splits, stock dividends and similar corporate events.
[F5]The option became exercisable as to 11,140 shares on August 7, 2017 and becomes exercisable in equal 11,140 share amounts on each of the 35 one-month anniversaries thereafter.
[F6]This option is fully vested.
[F7]One-third of the option becomes exercisable on August 16, 2020 and the remaining shares underlying the option become exercisable in equal increments on each of the 24 one-month anniversaries thereafter.

Documents

1 file

4
doc4_6617.xmlPrimary
PRIMARY DOCUMENT

Issuer

EYENOVIA, INC.

CIK 0001682639

→

Entity typeother

Related Parties

filerCIK 0001728916

Filing Metadata

Form type: 4
Filed: Mar 25, 8:00 PM ET
Accepted: Mar 26, 6:17 PM ET
Size: 18.3 KB

View on SEC.gov